Dr. Wolinsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Fannin St
Ste 1014
Houston, TX 77030Phone+1 832-325-7080Fax+1 713-512-2239
Summary
- Dr. Jerry Wolinsky is a neurologist in Houston, TX. He received his medical degree from University of Illinois College of Medicine at Chicago and has been in practice 48 years. He is experienced in multiple sclerosis, diffusion tensor imaging, encephalitis, magnetic resonance spectroscopy, and severity of illness index. He has more than 350 original publications and book chapters with over 60,000 citings. While retired from practice, he remains active as a consultant in clinical trials, and with the neuroimaging laboratory at UTHealth Houston.
Education & Training
University of California (San Francisco)Residency, Neurology, 1970 - 1973- University of California (San Francisco)/Mount ZionInternship, Transitional Year, 1969 - 1970
University of Illinois College of MedicineClass of 1969
Certifications & Licensure
TX State Medical License 1983 - 2024
MD State Medical License 1978 - 1991
CA State Medical License 1971 - 1978- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSafety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, pha...Xavier Montalban, Patrick Vermersch, Douglas L Arnold, Amit Bar-Or, Bruce A C Cree
The Lancet. Neurology. 2024-11-01 - Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning.Benjamin C Musall, Refaat E Gabr, Yanyu Yang, Arash Kamali, John A Lincoln
Scientific Reports. 2024-07-26 - 1 citationsPolygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis.Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C Fitzgerald, Amber Salter
Annals of Clinical and Translational Neurology. 2024-06-01
Journal Articles
- Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple SclerosisJerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine
Authored Content
- Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsJune 2020
Press Mentions
- Long-Term Ocrelizumab Shows Benefit in Progressive MSNovember 3rd, 2020
- Long-Term Ocrelizumab Benefits Seen in PPMSNovember 2nd, 2020
#ECTRIMS2019 – Early Ocrevus Use Slows Disability in PPMS, Including Risk of Wheelchair RelianceSeptember 17th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
